{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:37:47Z","timestamp":1790836667031,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T00:00:00Z","timestamp":1247097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T00:00:00Z","timestamp":1247097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1038\/gt.2009.85","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T10:17:53Z","timestamp":1247134673000},"page":"1340-1352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Mannitol-facilitated CNS entry of rAAV2 vector significantly delayed the neurological disease progression in MPS IIIB mice"],"prefix":"10.1038","volume":"16","author":[{"given":"D M","family":"McCarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"DiRosario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Gulaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Muenzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,9]]},"reference":[{"key":"BFgt200985_CR1","first-page":"3421","volume-title":"The Metabolic and Molecular Basis of Inherited Disease","author":"EF Neufeld","year":"2001","unstructured":"Neufeld EF, Muenzer J . The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic and Molecular Basis of Inherited Disease, 8th edn. McGraw-Hill: New York, St Louis, San Francisco, 2001, pp 3421\u20133452."},{"key":"BFgt200985_CR2","doi-asserted-by":"publisher","first-page":"14505","DOI":"10.1073\/pnas.96.25.14505","volume":"96","author":"HH Li","year":"1999","unstructured":"Li HH, Yu WH, Rozengurt N, Zhao HZ, Lyons KM, Anagnostaras S et al. Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc Natl Acad Sci USA 1999; 96: 14505\u201314510.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt200985_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/cne.20355","volume":"480","author":"R McGlynn","year":"2004","unstructured":"McGlynn R, Dobrenis K, Walkley SU . Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders. J Comp Neurol 2004; 480: 415\u2013426.","journal-title":"J Comp Neurol"},{"key":"BFgt200985_CR4","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/jnr.21134","volume":"85","author":"GR Villani","year":"2007","unstructured":"Villani GR, Gargiulo N, Faraonio R, Castaldo S, Gonzalez YRE, Di Natale P . Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB. J Neurosci Res 2007; 85: 612\u2013622.","journal-title":"J Neurosci Res"},{"key":"BFgt200985_CR5","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/jnr.21912","volume":"87","author":"J Dirosario","year":"2009","unstructured":"Dirosario J, Divers E, Wang C, Etter J, Charrier A, Jukkola P et al. Innate and adaptive immune activation in the brain of MPS IIIB mouse model. J Neurosci Res 2009; 87: 978\u2013990.","journal-title":"J Neurosci Res"},{"key":"BFgt200985_CR6","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1073\/pnas.252784899","volume":"100","author":"K Ohmi","year":"2003","unstructured":"Ohmi K, Greenberg DS, Rajavel KS, Ryazantsev S, Li HH, Neufeld EF . Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci USA 2003; 100: 1902\u20131907.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt200985_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1651-2227.2007.00202.x","volume":"96","author":"SU Walkley","year":"2007","unstructured":"Walkley SU . Pathogenic mechanisms in lysosomal disease: a reappraisal of the role of the lysosome. Acta Paediatr Suppl 2007; 96: 26\u201332.","journal-title":"Acta Paediatr Suppl"},{"key":"BFgt200985_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/jnr.10278","volume":"69","author":"HH Li","year":"2002","unstructured":"Li HH, Zhao HZ, Neufeld EF, Cai Y, Gomez-Pinilla F . Attenuated plasticity in neurons and astrocytes in the mouse model of Sanfilippo syndrome type B. J Neurosci Res 2002; 69: 30\u201338.","journal-title":"J Neurosci Res"},{"key":"BFgt200985_CR9","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1056\/NEJMp048084","volume":"350","author":"J Muenzer","year":"2004","unstructured":"Muenzer J, Fisher A . Advances in the treatment of mucopolysaccharidosis type I. N Engl J Med 2004; 350: 1932\u20131934.","journal-title":"N Engl J Med"},{"key":"BFgt200985_CR10","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.2165\/00003495-200767180-00005","volume":"67","author":"M Rohrbach","year":"2007","unstructured":"Rohrbach M, Clarke JT . Treatment of lysosomal storage disorders: progress with enzyme replacement therapy. Drugs 2007; 67: 2697\u20132716.","journal-title":"Drugs"},{"key":"BFgt200985_CR11","first-page":"252","volume":"6","author":"A Misra","year":"2003","unstructured":"Misra A, Ganesh S, Shahiwala A, Shah SP . Drug delivery to the central nervous system: a review. J Pharm Pharm Sci 2003; 6: 252\u2013273.","journal-title":"J Pharm Pharm Sci"},{"key":"BFgt200985_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1385\/MB:30:1:057","volume":"30","author":"WM Pardridge","year":"2005","unstructured":"Pardridge WM . Molecular biology of the blood-brain barrier. Mol Biotechnol 2005; 30: 57\u201370.","journal-title":"Mol Biotechnol"},{"key":"BFgt200985_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1023\/A:1007049806660","volume":"20","author":"SI Rapoport","year":"2000","unstructured":"Rapoport SI . Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications. Cell Mol Neurobiol 2000; 20: 217\u2013230.","journal-title":"Cell Mol Neurobiol"},{"key":"BFgt200985_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2174\/1567201043334542","volume":"1","author":"Y Chen","year":"2004","unstructured":"Chen Y, Dalwadi G, Benson HA . Drug delivery across the blood-brain barrier. Curr Drug Deliv 2004; 1: 361\u2013376.","journal-title":"Curr Drug Deliv"},{"key":"BFgt200985_CR15","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<637::AID-CNCR22>3.0.CO;2-Y","volume":"88","author":"ND Doolittle","year":"2000","unstructured":"Doolittle ND, Miner ME, Hall WA, Siegal T, Jerome E, Osztie E et al. Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. Cancer 2000; 88: 637\u2013647.","journal-title":"Cancer"},{"key":"BFgt200985_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1517\/17425247.2.2.299","volume":"2","author":"PJ Gaillard","year":"2005","unstructured":"Gaillard PJ, Visser CC, de Boer AG . Targeted delivery across the blood-brain barrier. Expert Opin Drug Deliv 2005; 2: 299\u2013309.","journal-title":"Expert Opin Drug Deliv"},{"key":"BFgt200985_CR17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.coph.2006.06.001","volume":"6","author":"WM Pardridge","year":"2006","unstructured":"Pardridge WM . Molecular Trojan horses for blood-brain barrier drug delivery. Curr Opin Pharmacol 2006; 6: 494\u2013500.","journal-title":"Curr Opin Pharmacol"},{"key":"BFgt200985_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1073\/pnas.76.1.481","volume":"76","author":"JA Barranger","year":"1979","unstructured":"Barranger JA, Rapoport SI, Fredericks WR, Pentchev PG, MacDermot KD, Steusing JK et al. Modification of the blood-brain barrier: increased concentration and fate of enzymes entering the brain. Proc Natl Acad Sci USA 1979; 76: 481\u2013485.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt200985_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ymthe.2004.08.031","volume":"11","author":"C Burger","year":"2005","unstructured":"Burger C, Nguyen FN, Deng J, Mandel RJ . Systemic mannitol-induced hyperosmolality amplifies rAAV2-mediated striatal transduction to a greater extent than local co-infusion. Mol Ther 2005; 11: 327\u2013331.","journal-title":"Mol Ther"},{"key":"BFgt200985_CR20","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1227\/00006123-199505000-00012","volume":"36","author":"SE Doran","year":"1995","unstructured":"Doran SE, Ren XD, Betz AL, Pagel MA, Neuwelt EA, Roessler BJ et al. Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption. Neurosurgery 1995; 36: 965\u2013970.","journal-title":"Neurosurgery"},{"key":"BFgt200985_CR21","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.ymthe.2003.08.021","volume":"8","author":"H Fu","year":"2003","unstructured":"Fu H, Muenzer J, Samulski RJ, Breese G, Sifford J, Zeng X et al. Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain. Mol Ther 2003; 8: 911\u2013917.","journal-title":"Mol Ther"},{"key":"BFgt200985_CR22","first-page":"1831","volume":"35","author":"EA Neuwelt","year":"1994","unstructured":"Neuwelt EA, Barnett PA, Hellstrom KE, Hellstrom I, McCormick CI, Ramsey FL . Effect of blood-brain barrier disruption on intact and fragmented monoclonal antibody localization in intracerebral lung carcinoma xenografts. J Nucl Med 1994; 35: 1831\u20131841.","journal-title":"J Nucl Med"},{"key":"BFgt200985_CR23","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1097\/00006123-199704000-00028","volume":"40","author":"BV Zlokovic","year":"1997","unstructured":"Zlokovic BV, Apuzzo ML . Cellular and molecular neurosurgery: pathways from concept to reality\u2014part II: vector systems and delivery methodologies for gene therapy of the central nervous system. Neurosurgery 1997; 40: 805\u2013812; discussion 812\u2013803.","journal-title":"Neurosurgery"},{"key":"BFgt200985_CR24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1006\/bbrc.2002.6495","volume":"291","author":"MF Ikeda","year":"2002","unstructured":"Ikeda MF, Bhattacharjee AKF, Kondoh TF, Nagashima TF, Tamaki N . Synergistic effect of cold mannitol and Na(+)\/Ca(2+) exchange blocker on blood-brain barrier opening. Biochem Biophys Res Commun 2002; 291: 669\u2013674.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFgt200985_CR25","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1126\/science.162.3853.570","volume":"162","author":"JC Fratantoni","year":"1968","unstructured":"Fratantoni JC, Hall CW, Neufeld EF . Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts. Science (New York, NY) 1968; 162: 570\u2013572.","journal-title":"Science (New York, NY)"},{"key":"BFgt200985_CR26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/BF00219337","volume":"88","author":"P Leinekugel","year":"1992","unstructured":"Leinekugel P, Michel S, Conzelmann E, Sandhoff K . Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet 1992; 88: 513\u2013523.","journal-title":"Hum Genet"},{"key":"BFgt200985_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000203880","volume":"95","author":"JL Abkowitz","year":"1996","unstructured":"Abkowitz JL, Persik MT, Catlin SN, Guttorp P . Simulation of hematopoiesis: implications for the gene therapy of lysosomal enzyme disorders. Acta Haematol 1996; 95: 213\u2013217.","journal-title":"Acta Haematol"},{"key":"BFgt200985_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/bies.950170310","volume":"17","author":"KI Berns","year":"1995","unstructured":"Berns KI, Linden RM . The cryptic life style of adeno-associated virus. Bioessays 1995; 17: 237\u2013245.","journal-title":"Bioessays"},{"key":"BFgt200985_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ng1094-148","volume":"8","author":"MG Kaplitt","year":"1994","unstructured":"Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O\u2019Malley KL et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994; 8: 148\u2013154.","journal-title":"Nat Genet"},{"key":"BFgt200985_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0006-8993(95)01488-8","volume":"713","author":"TJ McCown","year":"1996","unstructured":"McCown TJ, Xiao X, Li J, Breese GR, Samulski RJ . Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res 1996; 713: 99\u2013107.","journal-title":"Brain Res"},{"key":"BFgt200985_CR31","doi-asserted-by":"publisher","first-page":"5760","DOI":"10.1073\/pnas.102175599","volume":"99","author":"WS Sly","year":"2002","unstructured":"Sly WS, Vogler C . Brain-directed gene therapy for lysosomal storage disease: going well beyond the blood- brain barrier. Proc Natl Acad Sci USA 2002; 99: 5760\u20135762.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt200985_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1006\/mthe.2001.0514","volume":"5","author":"H Fu","year":"2002","unstructured":"Fu H, Samulski RJ, McCown TJ, Picornell YJ, Fletcher D, Muenzer J . Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene delivery. Mol Ther 2002; 5: 42\u201349.","journal-title":"Mol Ther"},{"key":"BFgt200985_CR33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/ana.20150","volume":"56","author":"N Desmaris","year":"2004","unstructured":"Desmaris N, Verot L, Puech JP, Caillaud C, Vanier MT, Heard JM . Prevention of neuropathology in the mouse model of Hurler syndrome. Ann Neurol 2004; 56: 68\u201376.","journal-title":"Ann Neurol"},{"key":"BFgt200985_CR34","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/sj.gt.3302961","volume":"14","author":"H Fu","year":"2007","unstructured":"Fu H, Kang L, Jennings JS, Moy SS, Perez A, Dirosario J et al. Significantly increased lifespan and improved behavioral performances by rAAV gene delivery in adult mucopolysaccharidosis IIIB mice. Gene Therapy 2007; 14: 1065\u20131077.","journal-title":"Gene Therapy"},{"key":"BFgt200985_CR35","doi-asserted-by":"publisher","first-page":"9321","DOI":"10.1523\/JNEUROSCI.2936-05.2005","volume":"25","author":"G Liu","year":"2005","unstructured":"Liu G, Martins I, Wemmie JA, Chiorini JA, Davidson BL . Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors. J Neurosci 2005; 25: 9321\u20139327.","journal-title":"J Neurosci"},{"key":"BFgt200985_CR36","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/ana.10373","volume":"52","author":"GG Heuer","year":"2002","unstructured":"Heuer GG, Passini MA, Jiang K, Parente MK, Lee VM, Trojanowski JQ et al. Selective neurodegeneration in murine mucopolysaccharidosis VII is progressive and reversible. Ann Neurol 2002; 52: 762\u2013770.","journal-title":"Ann Neurol"},{"key":"BFgt200985_CR37","doi-asserted-by":"publisher","first-page":"10229","DOI":"10.1523\/JNEUROSCI.3558-04.2004","volume":"24","author":"A Cressant","year":"2004","unstructured":"Cressant A, Desmaris N, Verot L, Brejot T, Froissart R, Vanier MT et al. Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum. J Neurosci 2004; 24: 10229\u201310239.","journal-title":"J Neurosci"},{"key":"BFgt200985_CR38","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","volume":"369","author":"MG Kaplitt","year":"2007","unstructured":"Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 2007; 369: 2097\u20132105.","journal-title":"Lancet"},{"key":"BFgt200985_CR39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/hum.2008.022","volume":"19","author":"S Worgall","year":"2008","unstructured":"Worgall S, Sondhi D, Hackett NR, Kosofsky B, Kekatpure MV, Neyzi N et al. Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA. Hum Gene Ther 2008; 19: 463\u2013474.","journal-title":"Hum Gene Ther"},{"key":"BFgt200985_CR40","first-page":"328","volume":"49","author":"MS Sands","year":"1999","unstructured":"Sands MS, Barker JE . Percutaneous intravenous injection in neonatal mice. Lab Anim Sci 1999; 49: 328\u2013330.","journal-title":"Lab Anim Sci"},{"key":"BFgt200985_CR41","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ymthe.2004.03.011","volume":"9","author":"SD Hartung","year":"2004","unstructured":"Hartung SD, Frandsen JL, Pan D, Koniar BL, Graupman P, Gunther R et al. Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase gene. Mol Ther 2004; 9: 866\u2013875.","journal-title":"Mol Ther"},{"key":"BFgt200985_CR42","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.ymthe.2004.10.006","volume":"11","author":"H Kobayashi","year":"2005","unstructured":"Kobayashi H, Carbonaro D, Pepper K, Petersen D, Ge S, Jackson H et al. Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector. Mol Ther 2005; 11: 776\u2013789.","journal-title":"Mol Ther"},{"key":"BFgt200985_CR43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2004.01.015","volume":"82","author":"RL Mango","year":"2004","unstructured":"Mango RL, Xu L, Sands MS, Vogler C, Seiler G, Schwarz T et al. Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs. Mol Genet Metab 2004; 82: 4\u201319.","journal-title":"Mol Genet Metab"},{"key":"BFgt200985_CR44","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","volume":"8","author":"DM McCarty","year":"2001","unstructured":"McCarty DM, Monahan PE, Samulski RJ . Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Therapy 2001; 8: 1248\u20131254.","journal-title":"Gene Therapy"},{"key":"BFgt200985_CR45","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ymgme.2006.11.006","volume":"90","author":"S Ryazantsev","year":"2007","unstructured":"Ryazantsev S, Yu WH, Zhao HZ, Neufeld EF, Ohmi K . Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III B. Mol Genet Metab 2007; 90: 393\u2013401.","journal-title":"Mol Genet Metab"},{"key":"BFgt200985_CR46","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1385\/NCC:1:2:219","volume":"1","author":"MN Diringer","year":"2004","unstructured":"Diringer MN, Zazulia AR . Osmotic therapy: fact and fiction. Neurocrit Care 2004; 1: 219\u2013233.","journal-title":"Neurocrit Care"},{"key":"BFgt200985_CR47","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3171\/jns.1992.76.5.0772","volume":"76","author":"WR Shapiro","year":"1992","unstructured":"Shapiro WR, Green SB, Burger PC, Selker RG, VanGilder JC, Robertson JT et al. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 1992; 76: 772\u2013781.","journal-title":"J Neurosurg"},{"key":"BFgt200985_CR48","first-page":"R443","volume":"256","author":"WC Cosolo","year":"1989","unstructured":"Cosolo WC, Martinello P, Louis WJ, Christophidis N . Blood-brain barrier disruption using mannitol: time course and electron microscopy studies. Am J Physiol 1989; 256: R443\u2013R447.","journal-title":"Am J Physiol"},{"key":"BFgt200985_CR49","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/sj.gt.3301420","volume":"8","author":"TM Daly","year":"2001","unstructured":"Daly TM, Ohlemiller KK, Roberts MS, Vogler CA, Sands MS . Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer. Gene Therapy 2001; 8: 1291\u20131298.","journal-title":"Gene Therapy"},{"key":"BFgt200985_CR50","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1073\/pnas.96.5.2296","volume":"96","author":"TM Daly","year":"1999","unstructured":"Daly TM, Vogler C, Levy B, Haskins ME, Sands MS . Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease. Proc Natl Acad Sci USA 1999; 96: 2296\u20132300.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt200985_CR51","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1203\/01.PDR.0000129661.40499.12","volume":"56","author":"BL Gliddon","year":"2004","unstructured":"Gliddon BL, Hopwood JJ . Enzyme-replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice. Pediatr Res 2004; 56: 65\u201372.","journal-title":"Pediatr Res"},{"key":"BFgt200985_CR52","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1517\/13543784.11.5.675","volume":"11","author":"ED Kakkis","year":"2002","unstructured":"Kakkis ED . Enzyme replacement therapy for the mucopolysaccharide storage disorders. Expert Opin Investig Drugs 2002; 11: 675\u2013685.","journal-title":"Expert Opin Investig Drugs"},{"key":"BFgt200985_CR53","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1651-2227.2002.tb03118.x","volume":"91","author":"J Muenzer","year":"2002","unstructured":"Muenzer J, Lamsa JC, Garcia A, Dacosta J, Garcia J, Treco DA . Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report. Acta Paediatr Suppl 2002; 91: 98\u201399.","journal-title":"Acta Paediatr Suppl"},{"key":"BFgt200985_CR54","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jpeds.2004.03.018","volume":"144","author":"P Harmatz","year":"2004","unstructured":"Harmatz P, Whitley CB, Waber L, Pais R, Steiner R, Plecko B et al. Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). J Pediatr 2004; 144: 574\u2013580.","journal-title":"J Pediatr"},{"key":"BFgt200985_CR55","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1203\/00006450-199606000-00019","volume":"39","author":"C Vogler","year":"1996","unstructured":"Vogler C, Sands MS, Levy B, Galvin N, Birkenmeier EH, Sly WS . Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival. Pediatr Res 1996; 39: 1050\u20131054.","journal-title":"Pediatr Res"},{"key":"BFgt200985_CR56","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1006\/prep.2000.1230","volume":"19","author":"KW Zhao","year":"2000","unstructured":"Zhao KW, Neufeld EF . Purification and characterization of recombinant human alpha-N-acetylglucosaminidase secreted by Chinese hamster ovary cells. Protein Expr Purif 2000; 19: 202\u2013211.","journal-title":"Protein Expr Purif"},{"key":"BFgt200985_CR57","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1006\/prep.2000.1361","volume":"21","author":"B Weber","year":"2001","unstructured":"Weber B, Hopwood JJ, Yogalingam G . Expression and characterization of human recombinant and alpha-N-acetylglucosaminidase. Protein Expr Purif 2001; 21: 251\u2013259.","journal-title":"Protein Expr Purif"},{"key":"BFgt200985_CR58","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/sj.gt.3300938","volume":"6","author":"S Zolotukhin","year":"1999","unstructured":"Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Therapy 1999; 6: 973\u2013985.","journal-title":"Gene Therapy"},{"key":"BFgt200985_CR59","doi-asserted-by":"publisher","first-page":"7323","DOI":"10.1523\/JNEUROSCI.21-18-07323.2001","volume":"21","author":"EC Warburton","year":"2001","unstructured":"Warburton EC, Baird A, Morgan A, Muir JL, Aggleton JP . The conjoint importance of the hippocampus and anterior thalamic nuclei for allocentric spatial learning: evidence from a disconnection study in the rat. J Neurosci 2001; 21: 7323\u20137330.","journal-title":"J Neurosci"},{"key":"BFgt200985_CR60","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0092-8674(00)80354-2","volume":"90","author":"N Lijam","year":"1997","unstructured":"Lijam N, Paylor R, McDonald MP, Crawley JN, Deng CX, Herrup K et al. Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell 1997; 90: 895\u2013905.","journal-title":"Cell"},{"key":"BFgt200985_CR61","first-page":"567","volume-title":"Techniques in Diagnostic Human Biochemical Genetics\u2014A Laboratory Manual","author":"JN Thompson","year":"1991","unstructured":"Thompson JN, Nowakoski RW . Enzymatic diagnosis of selected mucopolysaccharidoses: Hunter, Morquio type A, and Sanfilippo types A, B, C, and D, and procedures for measurement of 35SO4-glycosaminoglycans. In: Hommes FA (ed). Techniques in Diagnostic Human Biochemical Genetics\u2014A Laboratory Manual. Wiley-Liss: New York, 1991, pp 567\u2013586."},{"key":"BFgt200985_CR62","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1006\/abio.1994.1425","volume":"221","author":"CH van de Lest","year":"1994","unstructured":"van de Lest CH, Versteeg EM, Veerkamp JH, van Kuppevelt TH . Quantification and characterization of glycosaminoglycans at the nanogram level by a combined azure A-silver staining in agarose gels. Anal Biochem 1994; 221: 356\u2013361.","journal-title":"Anal Biochem"},{"key":"BFgt200985_CR63","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/clinchem\/35.7.1472","volume":"35","author":"JG de Jong","year":"1989","unstructured":"de Jong JG, Wevers RA, Laarakkers C, Poorthuis BJ . Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses. Clin Chem 1989; 35: 1472\u20131477.","journal-title":"Clin Chem"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt200985.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt200985","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt200985.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T09:49:43Z","timestamp":1648547383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt200985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,9]]},"references-count":63,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["BFgt200985"],"URL":"https:\/\/doi.org\/10.1038\/gt.2009.85","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,9]]},"assertion":[{"value":"6 January 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}